Bandhan Healthcare Fund - Regular Plan - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 10-11-2025
AUM:
294.7 Cr
Expense Ratio
2.41%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1KD0
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Viraj Kulkarni, Mr. Brijesh Shah, Ms. Ritika Behera and Mr. Gaurav Satra
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan Healthcare Fund - Regular Plan - IDCW | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
₹
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.531
Last change
0.05 (0.5351%)
Fund Size (AUM)
₹ 294.7 Cr
Performance
-4.27% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Fund Manager
Mr. Viraj Kulkarni, Mr. Brijesh Shah, Ms. Ritika Behera and Mr. Gaurav Satra
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.84 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 8.76 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.5 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.39 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.86 |
| Dr. Reddys Laboratories Ltd | 6.77 |
| JB Chemicals & Pharmaceuticals Limited | 5.57 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.51 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 3.43 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 3.05 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 95.56 |
| Financial Services | 2.27 |
| Information Technology | 0.23 |